Literature DB >> 26370676

Strategies for treatment of dystonia.

Dirk Dressler1, Eckart Altenmueller2, Roongroj Bhidayasiri3, Saeed Bohlega4, Pedro Chana5, Tae Mo Chung6, Steven Frucht7, Pedro J Garcia-Ruiz8, Alain Kaelin9, Ryuji Kaji10, Petr Kanovsky11, Rainer Laskawi12, Federico Micheli13, Olga Orlova14, Maja Relja15, Raymond Rosales16, Jaroslaw Slawek17, Sofia Timerbaeva18, Thomas T Warner19, Fereshte Adib Saberi20.   

Abstract

Treatment of dystonias is generally symptomatic. To produce sufficient therapy effects, therefore, frequently a multimodal and interdisciplinary therapeutic approach becomes necessary, combining botulinum toxin therapy, deep brain stimulation, oral antidystonic drugs, adjuvant drugs and rehabilitation therapy including physiotherapy, occupational therapy, re-training, speech therapy, psychotherapy and sociotherapy. This review presents the recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders Special Task Force on Interdisciplinary Treatment of Dystonia. It reviews the different therapeutic modalities and outlines a strategy to adapt them to the dystonia localisation and severity of the individual patient. Hints to emerging and future therapies will be given.

Entities:  

Keywords:  Antidystonic drugs; Botulinum toxin; Deep brain stimulation; Dystonia; Interdisciplinary approach; Multimodal therapies; Rehabilitation therapy; Treatment strategies

Mesh：

Year:  2015        PMID： 26370676     DOI： 10.1007/s00702-015-1453-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  26 in total

1.  An investigation of neurosurgical alleviation of parkinsonism, chorea, athetosis and dystonia.

Authors:  I S COOPER
Journal:  Ann Intern Med       Date:  1956-09       Impact factor: 25.391

2.  Delta9-tetrahydrocannabinol improves motor control in a patient with musician's dystonia.

Authors:  Hans-Christian Jabusch; Udo Schneider; Eckart Altenmüller
Journal:  Mov Disord       Date:  2004-08       Impact factor: 10.338

3.  Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assay.

Authors:  Dirk Dressler; Gerd Mander; Klaus Fink
Journal:  J Neural Transm (Vienna)       Date:  2011-10-05       Impact factor: 3.575

4.  Musician's dystonia in pianists: long-term evaluation of retraining and other therapies.

Authors:  F T van Vugt; L Boullet; H-C Jabusch; E Altenmüller
Journal:  Parkinsonism Relat Disord       Date:  2013-08-30       Impact factor: 4.891

5.  Successful treatment of musician's dystonia using repetitive transcranial magnetic stimulation.

Authors:  Klaus Kieslinger; Yvonne Höller; Jürgen Bergmann; Stefan Golaszewski; Wolfgang Staffen
Journal:  Clin Neurol Neurosurg       Date:  2013-04-22       Impact factor: 1.876

6.  Selective peripheral denervation for spasmodic torticollis: surgical technique, results, and observations in 260 cases.

Authors:  C M Bertrand
Journal:  Surg Neurol       Date:  1993-08

7.  The treatment of severe dystonia in children and adults.

Authors:  C D Marsden; M H Marion; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

8.  Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.

Authors:  Jens Volkmann; Alexander Wolters; Andreas Kupsch; Jörg Müller; Andrea A Kühn; Gerd-Helge Schneider; Werner Poewe; Sascha Hering; Wilhelm Eisner; Jan-Uwe Müller; Günther Deuschl; Marcus O Pinsker; Inger-Marie Skogseid; Geir Ketil Roeste; Martin Krause; Volker Tronnier; Alfons Schnitzler; Jürgen Voges; Guido Nikkhah; Jan Vesper; Joseph Classen; Markus Naumann; Reiner Benecke
Journal:  Lancet Neurol       Date:  2012-11-01       Impact factor: 44.182

9.  Lasting effects of repeated rTMS application in focal hand dystonia.

Authors:  Michael Borich; Sanjeev Arora; Teresa Jacobson Kimberley
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

10.  Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study.

Authors:  Marie Vidailhet; Laurent Vercueil; Jean-Luc Houeto; Pierre Krystkowiak; Christelle Lagrange; Jerôme Yelnik; Eric Bardinet; Alim-Louis Benabid; Soledad Navarro; Didier Dormont; Sylvie Grand; Serge Blond; Claire Ardouin; Bernard Pillon; Katy Dujardin; Valérie Hahn-Barma; Yves Agid; Alain Destée; Pierre Pollak
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182
View more
  9 in total

1.  Clinical Pharmacology of Botulinum Toxin Drugs.

Authors:  Dirk Dressler
Journal:  Handb Exp Pharmacol       Date:  2021

2.  Dystonia treatment: Patterns of medication use in an international cohort.

Authors:  Sarah Pirio Richardson; Ashley R Wegele; Betty Skipper; Amanda Deligtisch; H A Jinnah
Journal:  Neurology       Date:  2017-01-11       Impact factor: 9.910

3.  Combined cognitive-behavioural and mindfulness programme for people living with dystonia: a proof-of-concept study.

Authors:  H Sandhu; C J Bernstein; G Davies; N K Y Tang; M Belhag; A Tingle; M Field; J Foss; A Lindahl; M Underwood; D R Ellard
Journal:  BMJ Open       Date:  2016-08-05       Impact factor: 2.692

Review 4.  Medical treatment of dystonia.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2016-12-19

5.  Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study.

Authors:  S C Drexel; M Klietz; F Wegner; D Dressler; K Kollewe; L Paracka; A Kutschenko; B Kopp; F Lange
Journal:  J Neural Transm (Vienna)       Date:  2019-12-04       Impact factor: 3.575

Review 6.  Botulinum toxin therapy: past, present and future developments.

Authors:  Dirk Dressler; Eric A Johnson
Journal:  J Neural Transm (Vienna)       Date:  2022-04-09       Impact factor: 3.850

Review 7.  Botulinum toxin therapy of dystonia.

Authors:  Dirk Dressler; Fereshte Adib Saberi; Raymond L Rosales
Journal:  J Neural Transm (Vienna)       Date:  2020-10-30       Impact factor: 3.575

8.  A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus.

Authors:  Gerard E Francisco; Alexander Balbert; Ganesh Bavikatte; Djamel Bensmail; Stefano Carda; Thierry Deltombe; Nathalie Draulans; Steven Escaldi; Raphael Gross; Jorge Jacinto; Nicholas Ketchum; Franco Molteni; Susana Moraleda; Michael W ODell; Rajiv Reebye; Patrik Säterö; Monica Verduzco-Gutierrez; Heather Walker; Jörg Wissel
Journal:  J Rehabil Med       Date:  2021-01-01       Impact factor: 2.912

9.  Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II.

Authors:  Ruth Kent; Adrian Robertson; Sandra Quiñones Aguilar; Charalampos Tzoulis; John Maltman
Journal:  Toxins (Basel)       Date:  2021-07-14       Impact factor: 4.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.